Epigenetic therapeutics is fastest growing segment fueling the growth of Netherlands Compounding Pharmacies Market
![]() |
| Netherlands Compounding Pharmacies Market |
The global Netherlands Compounding Pharmacies Market is estimated to be valued at US$ 520.5 Mn in 2023 and is expected to exhibit a CAGR of 8.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Compounding pharmacies prepare customized medications tailor-made to patient's
needs. They re-purpose FDA-approved ingredients into medications in alternative
formulations like creams, gels, or liquids when commercial products are not
suitable. This increases treatment options and adherence.
Market key trends:
One of the key trends in the Netherlands Compounding Pharmacies Market is the
rise in demand for personalized medications. With growing awareness about
tailored treatment options, there is increasing demand for medications
compounded to suit an individual's unique needs like allergies, ability to
swallow pills, or other considerations. This is driving more pharmacies to
offer compounding services and is fueling the market growth.
Segment Analysis
The Netherlands compounding pharmacies market is segmented by dosage form into
capsules, tablets, topical preparations, oral solutions and suspensions, and
others. Among these, the topical preparations segment holds the largest share
of the market and is expected to remain the dominant segment over the forecast
period. This is attributed to the growing demand for topical medications like
creams, gels, and ointments to treat skin problems like acne, eczema, and other
dermatological conditions prevalent in the country.
Key Takeaways
The global Netherlands
Compounding Pharmacies Market Share is expected to witness high growth, exhibiting
CAGR of 8.5% over the forecast
period, due to increasing prevalence of chronic conditions like cardiovascular
diseases, diabetes, cancer, and neurological disorders in the country.
Regional analysis
The market in North Holland region currently dominates the Netherlands
compounding pharmacies market and is expected to maintain its lead over the
forecast period. This can be attributed to the presence of major pharmaceutical
companies in cities like Amsterdam and Alkmaar. However, the South Holland
region is anticipated to witness the fastest growth over the next few years
owing to increasing healthcare investments and expanding healthcare
infrastructure in major cities like Rotterdam and The Hague.
Key players
Key players operating in the Netherlands compounding pharmacies market include
Apotheek Zur Rose, Viataal, Stichting De Apothekerscoöperatie, and Holland
Pharma. Apotheek Zur Rose holds the largest share of over 15% in the market and
offers a wide range of customized medications through its online platform and
brick-and-mortar stores across major cities.
For more
insights, Read- https://www.ukwebwire.com/netherlands-compounding-pharmacies-market-trends-size-and-share-analysis/

Comments
Post a Comment